Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.22.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.22.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.22.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GS.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GS.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GS.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HK.24NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HK.24NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.24NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XCFNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XCFNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XCFNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CH.1.1.32NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CH.1.1.32NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CH.1.1.32NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.109NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.109NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.109NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FR.1.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FR.1.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FR.1.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.10NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.10NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HK.12NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HK.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.12NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HK.33NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HK.33NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.33NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GK.5.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GK.5.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.5.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XCZNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XCZNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XCZNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.40NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GE.1.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GE.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GE.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HE.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HE.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HE.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.33NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.33NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.33NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FY.4.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FY.4.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.4.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.99NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used